Table 1 Clinical characteristics for all subjects (n = 60)
Risk factors | |
Age (years)1 | 57 ± 10 |
Male | 49 (81.67%) |
Diabetes mellitus | 3 (5%) |
Hypertension | 25 (41.67%) |
Hypercholesterolemia | 30 (50%) |
Tobacco use | 30 (50%) |
Clinical Data | |
Symptom-to-balloon (median) (min) | 197 |
Door-to-balloon (median) (min) | 85.5 |
Maximum total CK MB (IU/L)1 | 243.65 ± 239.64 |
Maximum total Troponine T (ng/L)1 | 53.43 ± 80.65 |
Angiographic findings | |
Left anterior descending IRA | 33 (55%) |
Left circumflex IRA | 6 (10%) |
Right coronary IRA | 21 (35%) |
TIMI pre-procedure | |
TIMI 0 | 43 (71.67%) |
TIMI 1 | 10 (16.67%) |
TIMI 2 | 5 (8.33%) |
TIMI 3 | 2 (3.33%) |
TIMI post-procedure | |
TIMI 2 | 7 (11.67%) |
TIMI 3 | 53 (88.33%) |
Rentrop Scale | |
0 | 22 (36.67%) |
1 | 16 (26.67%) |
2 | 15 (25%) |
3 | 7 (11.67%) |
MRI Data | |
Acute MRI | |
End-diastolic volume (mL)1 | 154.35 ± 30.72 |
End-systolic volume (mL)1 | 85.14 ± 29.55 |
Ejection Fraction (%)1 | 45.83 ± 11.47 |
Infarct mass (gr)1 | 24.12 ± 16.15 |
Chronic MRI | |
End-diastolic volume (mL)1 | 161.65 ± 30.73 |
End-systolic volume (mL)1 | 79.12 ± 28.13 |
Ejection Fraction (%)1 | 52.16 ± 10.82 |
Infarct mass (gr)1 | 13.74 ± 10.46 |
Medication use | |
IIB-IIIA inhibitor | 58 (96.67%) |
Antiplatelet (aspirine and/or clopidogrel) | 58 (96.67%) |
β-Blocker | 58 (96.67%) |
ACE inhibitor | 51 (85%) |
Statin | 56 (94%) |